FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称OCRELIZUMAB
异名/同义词IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL 2H7 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2H7 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL 2H7 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL 2H7 .KAPPA.-CHAIN, DIMER
OCRELIZUMAB
OCRELIZUMAB [INN]
OCRELIZUMAB [JAN]
OCRELIZUMAB [MI]
OCRELIZUMAB [PURPLE BOOK CDER]
OCRELIZUMAB [USAN]
OCRELIZUMAB [WHO-DD]
OCRELIZUMAB-OCSQ
OCREVUS
OCREVUS ZUNOVO COMPONENT OCRELIZUMAB
PR070769
PR-070769
R-1594
RG-1594
CAS登记号637334-45-3
物质唯一标识(Unique Ingredient Identifier)A10SJL62JY
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System